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OBJECTIVES: This study aimed to evaluate the impact of pharmacist-provided discharge counseling on mortality
rate, hospital readmissions, emergency department visits, and medication adherence at 30 days post discharge.
METHODS: This randomized controlled trial was approved by the local ethics committee and included patients
aged 18 years or older admitted to the cardiology ward of a Brazilian tertiary hospital. The intervention group
received a pharmacist-led medication counseling session at discharge and a telephone follow-up three and
15 days after discharge. The outcomes included the number of deaths, hospital readmissions, emergency
department visits, and medication adherence. All outcomes were evaluated during a pharmacist-led ambulatory
consultation performed 30 days after discharge.
RESULTS: Of 133 patients, 104 were included in the analysis (51 and 53 in the intervention and control groups,
respectively). The intervention group had a lower overall readmission rate, number of emergency department
visits, and mortality rate, but the differences were not statistically significant (p40.05). However, the interven-
tion group had a significantly lower readmission rate related to heart disease (0% vs. 11.3%, p=0.027), despite
the small sample size. Furthermore, medication counseling contributed significantly to improved medication
adherence according to three different tools (po0.05).
CONCLUSIONS: Pharmacist-provided discharge medication counseling resulted in better medication adherence
scores and a lower incidence of cardiovascular-associated hospital readmissions, thus representing a useful
service for cardiology patients.
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’ INTRODUCTION
Medication errors are an important risk factor for hospita-
lization and mortality (1,2). Several factors contribute to
increased readmission rates, including time to primary care
follow-up, adverse drug events (3,4), medication nonadherence
(5), medication discrepancies (6,7), insufficient discharge plan-
ning (8), and lack of continuity in care (9). Medical conditions
associated with high rates of re-hospitalization include conges-
tive heart failure, acute myocardial infarction (AMI), pneumo-
nia, diabetes, and chronic obstructive pulmonary disease (9).
Up to 67% of patients admitted to hospitals have
medication discrepancies that often persist at discharge (10).
One observational study reported that patients with medication
discrepancies had a 30-day hospital readmission rate of 14.3%,
compared with 6.1% in patients without discrepancies (6). The
consequences of these issues affect patient safety as well as the
quality and cost of care (6,11). The World Health Organization
estimates that only 50% of individuals with chronic diseases
adhere to their medication regimen (12). Recent studies have
demonstrated that adherence to cardioprotective medications,
such as statins and clopidogrel, is poor in the first year after
acute coronary syndrome. After AMI, nearly 24% of patients do
not fill their medications within seven days of discharge, and
one-third of patients decide to stop at least one medication in
the first month (5,13).
Pharmacists may play a significant role in the transition
of care, especially in reducing readmissions by ensuring that
appropriate, evidence-based pharmacotherapy regimens have
been prescribed during hospitalization, identifying medica-
tion errors, and performing medication reconciliation (8).
The results of several studies suggest that medication
counseling before hospital discharge reduces the incidence of
patient medication discrepancies and adverse drug events
(4,7). Counseling also improves adherence (14,15), decreases
readmission rates (1,16) and mortality (5), and consequentlyDOI: 10.6061/clinics/2018/e325
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results in cost savings (17,18); however, other reports have
suggested that counseling has little or no effect (19,20).
Medication counseling can ensure that patients are appro-
priately educated about their medications. However, most
previous studies have been conducted in high-income coun-
tries, and the endpoints were evaluated via telephone inter-
views. Therefore, the aim of this trial was to assess the impact
of pharmacist-led medication counseling at hospital discharge
on mortality rate, hospital readmissions (related and unrelated
to heart disease), emergency department visits (related and
unrelated to heart disease), and medication adherence in a
developing country.
’ METHODS
This randomized controlled trial was performed according
to CONSORT guidelines and was conducted in a tertiary
hospital in Curitiba, Brazil, from February to December 2015.
This hospital has 360 beds and admits approximately
30 patients per month on the cardiology ward. Patients aged
18 years and older were eligible if they were admitted to a
specialized cardiology ward due to stable angina, acute coro-
nary syndrome, congestive heart failure, valvular disease,
arrhythmias, or hypertension. The exclusion criteria included
patients with cognitive impairment and without a caregiver,
palliative care status, and subjects who refused to participate
in this study. Patients transferred to other clinical specialties
or institutions and those who were not discharged from the
hospital before the end of the study were also excluded.
The sample size was calculated considering 5.0% type I
and 20% type II error (80% power) rates based on hospital
readmission rates reported in the literature, resulting in
53 patients in each group. Following the randomization
procedures, the participants were randomly assigned to one
of two groups. Eligible patients who provided informed
consent were allocated to either the intervention group or
control group in a 1:1 ratio using a random number list gene-
rated by a third person using Microsoft Office Excel 2010s.
The sequence of inclusion corresponded to the hospital
admission order. Two cardiovascular pharmacy residents were
responsible for patient enrollment according to the eligibility
criteria and for performing the intervention. These pharmacy
residents were in the department daily, and they received
coaching during the first year of residency.
Patients who were allocated to the intervention group or
their caregivers received individual counseling sessions regard-
ing the discharge prescriptions. These sessions included a
thorough assessment of the pharmacotherapy and interven-
tions from cardiologists in order to correct any medication
issues, as well as an explanation about the indications, benefits,
therapeutic targets, dose, dosing schedule, routes, storage,
length of therapy, refill pharmacy, and possible adverse drug
events for each prescribed drug. A leaflet containing the infor-
mation provided in the verbal counseling was delivered by
the pharmacists. Subsequently, patients were contacted by
telephone three and 15 days post-discharge to reinforce the
previous counseling session. All pharmacist interventions were
performed and described according the Descriptive Elements of
Pharmacist Interventions Characterization Tool (DEPICT) (21).
The control group received usual care from pharmacists
and other healthcare providers. During the hospitalization,
all patients, including those from the control group, received
pharmaceutical interventions as necessary. At the time of
hospital discharge, patients from both groups were scheduled
for an appointment 30 days post-discharge in the Pharmaceutical
Care Ambulatory Clinic of the same hospital. During this
appointment, the pharmacist team for the ambulatory clinic
collected data regarding the participant outcomes and per-
formed counseling for both groups as necessary. Subsequently,
all patients were followed equally by the ambulatory clinic.
There were five trained pharmacists in this setting, including one
of the residents who provided the intervention.
The primary endpoints were mortality rate, hospital
readmissions (related and unrelated to heart disease), and
emergency department visits (related and unrelated to heart
disease) within 30 days. We asked the patients whether they
visited emergency departments during this period and
whether they were admitted to another hospital.
The secondary endpoint was medication adherence based
on the results of the MedTake (22), Beliefs about Medicines
Questionnaire (BMQ) (23), and Adherence to Refills and
Medications Scale (ARMS) (24) instruments, all completed
30 days post-discharge. The MedTake test is a quantitative
assessment of drug-taking procedures for oral prescriptions
that is used to screen for medication adherence problems.
The test evaluates dosage (number of dosage units), indica-
tions, food or water co-ingestion, and regimens. Each test is
scored as the percentage of correct actions (0%: zero adherence;
100%: total adherence) (22). To better interpret the overall
results, we divided the results into MedTake 1, and MedTake 2,
defined as the percentage of drugs that the patient was taking
properly and the percentage of drugs for which the patient was
aware of the indications, respectively. The BMQ is a ques-
tionnaire composed of two subscales: a five-item necessity
scale to assess beliefs about the necessity for medication and a
six-item concerns scale to assess beliefs about the danger of
dependence and the disruptive effects of medication. Each item
is scored on a five-point scale (1=strongly disagree, 2=disagree,
3=uncertain, 4=agree and 5=strongly agree); the final result is
obtained by the quotient between the percentage of the sum of
‘‘necessity’’ and ‘‘concern’’ questions (23). Higher scores indicate
greater awareness of the necessity for taking the medications,
decreased concern regarding the possible negative effects, and
better medication adherence. Finally, the ARMS instrument is a
medication adherence scale intended for patients with chronic
medical conditions. It includes a total of 14 items, each of which
is structured with responses ‘‘none,’’ ‘‘some,’’ ‘‘most,’’ or ‘‘all’’ of
the time, which are assigned values from 1 to 4, respectively.
The questionnaire contains questions about the frequency
of medication withdrawal in healthcare institutions (‘‘refill’’)
and about forgetfulness in taking medications (‘‘taking’’) (24).
Patients with better medication adherence have scores near 12,
whereas patients with no adherence have scores of 48.
Statistical analyses were conducted using SPSS Statistics
for Windows, version 22.0. Kolmogorov-Smirnov tests were
used to assess the normality of the distribution of the investi-
gated parameters. Student’s t and Mann-Whitney tests were used
for continuous data as appropriate, and categorical variables were
assessed using chi-square and Fisher’s exact tests. P values lower
than 0.05 were considered statistically significant.
Ethics approval
This trial was in performed accordance with the standards
of the institution’s ethics committee (approval number:
40431015.8.0000.0096), the national research committee, and
the 1983 Helsinki declaration and its later amendments or
comparable ethical standards.
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’ RESULTS
Of the 167 eligible patients recruited between February
and November 2015, 133 agreed to participate, and 34 were
excluded. A total of 66 and 67 patients were allocated to the
intervention and control groups, respectively, and patient
follow-up occurred through December 2015 (Figure 1).
There were no statistically significant differences in base-
line characteristics between the two groups (Table 1). The
mean age of the participants was 65 years, most were men,
and all of the participants were on polypharmacy. The most
frequent reason for hospitalization was AMI, followed by
unstable angina, congestive heart failure, and atrial fibrillation.
Figure 1 - Flow diagram of the intervention and control groups in the randomized trial.
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The most common comorbidities were hypertension, diabetes,
and dyslipidemia.
There were three deaths during the 30 days post-dis-
charge, all in the control group. These patients were included
in the primary endpoint analysis, but the difference between
the intervention and control groups was not statistically
significant (p=0.243; Table 2).
The rate of hospital readmissions related to heart disease
was significantly lower in the intervention group than in
the control group (p=0.027). Overall readmissions and emer-
gency department visits related to heart disease were higher
in the control group, but the differences were not statistically
significant (p=0.374 and p=0.118, respectively; Table 2).
The mean scores of each adherence instrument revealed
that the intervention group was significantly more adherent
to medications than the control group (po0.05; Table 3).
’ DISCUSSION
This study revealed that medication counseling at dis-
charge decreased early readmission rates, especially related
to heart disease, and improved medication adherence. These
outcomes were evaluated during a pharmaceutical appoint-
ment, unlike previous studies, indicating the potential for
pharmacotherapeutic follow-up of patients. This is the first
study to evaluate the impact of medication counseling on
readmission rates, emergency department visits, deaths, and
medication adherence using three different tools.
According to similar studies, pharmacist-led medication
review, patient counseling, and telephone follow-up are
associated with lower readmission rates after hospital dis-
charge; however, some of these results were not statistically
significant (19,25-27), and some of these studies were con-
ducted as non-randomized trials (1,15,27).
A prospective study reported that older age, history of
diabetes, a greater number of prescriptions before AMI,
and history of congestive heart failure are associated with
increased one-year mortality. Patients who received dis-
charge counseling from pharmacists had a lower risk of one-
year mortality (p=0.001) (5). Our study did not observe a
statistically significant reduction in mortality among patients
with these characteristics; however, we evaluated early
mortality in a randomized controlled trial design, whereas
the previous study was a cohort design that analyzed one-
year mortality following AMI.
A similar randomized trial revealed that patients who
received discharge medication counseling from nurses and
telephone follow-up from pharmacists exhibited lower rates
of hospital utilization than usual care participants (p=0.009),
but there was no difference in early readmission rates (p=
0.090) (17). Another study evaluated the impact of the phar-
macy team in transition-of-care settings and demonstrated
reduced composite emergency department visits and in-
patient readmissions (p=0.022) but reported no significant
differences in hospital readmission rates separately (p=0.43)
(28). Conversely, our study revealed lower 30-day read-
mission rates due to cardiac diseases in patients who were
allocated to the intervention group, emphasizing that medi-
cation counseling may be important for cardiology patients
with polypharmacy to reduce readmission rates caused by
improper use of medication.
We also observed that discharge counseling and pharma-
cotherapy follow-up by phone were essential for medication
Table 1 - Patient characteristics at baseline.
Variable* Intervention (n=51) Control (n=53) p***
Age (years) 65 (±10) 65 (±13) 0.939
Men, n (%) 35 (68.6) 34 (64.2) 0.629
Number of comorbidities 4 (±1) 4 (±2) 0.929
Number of medications at discharge 7 (±2) 8 (±3) 0.430
Number of medications at ambulatory follow-up** 8 (±3) 9 (±3) 0.250
Days of hospitalization 10 (±9) 12 (±9) 0.273
Presence of caregiver, n (%) 14 (28) 17 (34) 0.517
*Mean and SD are reported for continuous data.
**n=49 in each group.
*** Statistically significant if po0.05.
Table 2 - Primary endpoint results.
Endpoints* Intervention (n=51) Control (n=53) p**
Emergency department visits related to heart disease 0 4 (7.5) 0.118
Emergency department visits not related to heart disease 3 (5.9) 1 (1.9) 0.289
Total hospital readmissions 4 (7.8) 7 (13.2) 0.374
Hospital readmissions related to heart disease 0 (0) 6 (11.3) 0.027
Hospital readmissions not related to heart disease 4 (7.8) 1 (1.9) 0.156
Deaths 0 (0) 3 (5.7) 0.243
*Data are reported as absolute and relative numbers (%).
** Statistically significant if po0.05.
Table 3 - Secondary endpoint results.
Endpoints* Intervention (n=49) Control (n=49) p**
Total MedTake 92.1 (±9.9) 58.5 (±31.9) o0.001
MedTake 1 95.2 (±8.6) 64.7 (±37.1) o0.001
MedTake 2 85.2 (±21.5) 44.5 (±34.8) o0.001
BMQ 1.8 (±0.6) 1.6 (±0.5) 0.028
ARMS 13 (±2) 15 (±4) 0.001
*Mean and SD are reported for the data.
** Statistically significant if po0.05.
Abbreviations: ARMS: Adherence to Refills and Medications Scale;
BMQ: Beliefs about Medicines Questionnaire.
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adherence. The intervention group had significantly higher
mean total MedTake, MedTake 1, and MedTake 2 percen-
tages compared with the control group, indicating that the
pharmacist-led counseling contributed to an increased patient
understanding of the medication-taking process and the
indications for each medication. Other factors may contribute
to medication adherence, including patient resources, atti-
tudes, beliefs, perceptions, and expectations towards medica-
tion (29). However, we observed that the intervention group
was significantly more adherent to their medications than the
control group based on the BMQ and ARMS results.
The limitations of this study include a small patient
population that, despite exceeding the minimum sample size
calculations, may have resulted in an underestimation of
the effect of the intervention. However, our trial is under-
powered to adequately study mortality, other causes of
hospital readmissions, and emergency department visits.
We note that not everyone in the ambulatory setting was
blinded to the study allocation, but the primary outcomes are
objective and consequently were not affected by the lack of
blinding. Another limitation is that the intervention group
could have been affected by the Hawthorn effect, contribut-
ing to the positive results.
The results of this study revealed that discharge medica-
tion counseling performed by pharmacists decreased 30-day
hospital readmissions, particularly those related to cardiac
disease, and improved medication adherence in cardiology
patients under polypharmacy. Transition of care is a high-
risk situation for many patients, and abundant discharge
counseling is needed. The involvement of pharmacists in the
transition of care is advisable to reduce re-hospitalization
related to inappropriate use of medications.
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